View in EDS

Cabozantinib plus durvalumab in advanced gastroesophageal cancer and other gastrointestinal malignancies: Phase Ib CAMILLA trial results.

Saved in:
Bibliographic Details
Title: Cabozantinib plus durvalumab in advanced gastroesophageal cancer and other gastrointestinal malignancies: Phase Ib CAMILLA trial results.
Authors: Saeed A; Department of Medicine, Division of Medical Oncology, Kansas University Medical Center, Kansas City, KS 66160, USA; Kansas University Cancer Center, Kansas City, KS 66205, USA; Department of Medicine, Division of Hematology and Oncology, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA 15213, USA. Electronic address: dranwaarsaeed1@gmail.com., Park R; Division of Hematology and Medical Oncology, Moffitt Cancer Center, Tampa, FL 33612, USA., Dai J; Department of Biostatistics, Kansas University Medical Center, Kansas City, KS 66160, USA., Al-Rajabi R; Department of Medicine, Division of Medical Oncology, Kansas University Medical Center, Kansas City, KS 66160, USA; Kansas University Cancer Center, Kansas City, KS 66205, USA., Kasi A; Department of Medicine, Division of Medical Oncology, Kansas University Medical Center, Kansas City, KS 66160, USA; Kansas University Cancer Center, Kansas City, KS 66205, USA., Baranda J; Department of Medicine, Division of Medical Oncology, Kansas University Medical Center, Kansas City, KS 66160, USA; Kansas University Cancer Center, Kansas City, KS 66205, USA., Williamson S; Department of Medicine, Division of Medical Oncology, Kansas University Medical Center, Kansas City, KS 66160, USA; Kansas University Cancer Center, Kansas City, KS 66205, USA., Saeed A; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455, USA., Ripp J; Department of Medicine, Division of Medical Oncology, Kansas University Medical Center, Kansas City, KS 66160, USA., Collins Z; Department of Radiology, Kansas University Medical Center, Kansas City, KS 66160, USA., Mulvaney K; Kansas University Cancer Center, Kansas City, KS 66205, USA., Shugrue M; Kansas University Cancer Center, Kansas City, KS 66205, USA., Firth-Braun J; Kansas University Cancer Center, Kansas City, KS 66205, USA., Godwin AK; Kansas University Cancer Center, Kansas City, KS 66205, USA; Department of Pathology and Laboratory Medicine, Kansas University Medical Center, Kansas City, KS 66160, USA., Madan R; Department of Pathology and Laboratory Medicine, Kansas University Medical Center, Kansas City, KS 66160, USA., Phadnis M; Department of Biostatistics, Kansas University Medical Center, Kansas City, KS 66160, USA., Sun W; Department of Medicine, Division of Medical Oncology, Kansas University Medical Center, Kansas City, KS 66160, USA; Kansas University Cancer Center, Kansas City, KS 66205, USA.
Source: Cell reports. Medicine [Cell Rep Med] 2023 Feb 21; Vol. 4 (2), pp. 100916. Date of Electronic Publication: 2023 Jan 25.
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101766894 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-3791 (Electronic) Linking ISSN: 26663791 NLM ISO Abbreviation: Cell Rep Med Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36702123
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Cabozantinib plus durvalumab in advanced gastroesophageal cancer and other gastrointestinal malignancies: Phase Ib CAMILLA trial results.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Saeed+A%22">Saeed A</searchLink>; Department of Medicine, Division of Medical Oncology, Kansas University Medical Center, Kansas City, KS 66160, USA; Kansas University Cancer Center, Kansas City, KS 66205, USA; Department of Medicine, Division of Hematology and Oncology, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA 15213, USA. Electronic address: dranwaarsaeed1@gmail.com.<br /><searchLink fieldCode="AU" term="%22Park+R%22">Park R</searchLink>; Division of Hematology and Medical Oncology, Moffitt Cancer Center, Tampa, FL 33612, USA.<br /><searchLink fieldCode="AU" term="%22Dai+J%22">Dai J</searchLink>; Department of Biostatistics, Kansas University Medical Center, Kansas City, KS 66160, USA.<br /><searchLink fieldCode="AU" term="%22Al-Rajabi+R%22">Al-Rajabi R</searchLink>; Department of Medicine, Division of Medical Oncology, Kansas University Medical Center, Kansas City, KS 66160, USA; Kansas University Cancer Center, Kansas City, KS 66205, USA.<br /><searchLink fieldCode="AU" term="%22Kasi+A%22">Kasi A</searchLink>; Department of Medicine, Division of Medical Oncology, Kansas University Medical Center, Kansas City, KS 66160, USA; Kansas University Cancer Center, Kansas City, KS 66205, USA.<br /><searchLink fieldCode="AU" term="%22Baranda+J%22">Baranda J</searchLink>; Department of Medicine, Division of Medical Oncology, Kansas University Medical Center, Kansas City, KS 66160, USA; Kansas University Cancer Center, Kansas City, KS 66205, USA.<br /><searchLink fieldCode="AU" term="%22Williamson+S%22">Williamson S</searchLink>; Department of Medicine, Division of Medical Oncology, Kansas University Medical Center, Kansas City, KS 66160, USA; Kansas University Cancer Center, Kansas City, KS 66205, USA.<br /><searchLink fieldCode="AU" term="%22Saeed+A%22">Saeed A</searchLink>; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455, USA.<br /><searchLink fieldCode="AU" term="%22Ripp+J%22">Ripp J</searchLink>; Department of Medicine, Division of Medical Oncology, Kansas University Medical Center, Kansas City, KS 66160, USA.<br /><searchLink fieldCode="AU" term="%22Collins+Z%22">Collins Z</searchLink>; Department of Radiology, Kansas University Medical Center, Kansas City, KS 66160, USA.<br /><searchLink fieldCode="AU" term="%22Mulvaney+K%22">Mulvaney K</searchLink>; Kansas University Cancer Center, Kansas City, KS 66205, USA.<br /><searchLink fieldCode="AU" term="%22Shugrue+M%22">Shugrue M</searchLink>; Kansas University Cancer Center, Kansas City, KS 66205, USA.<br /><searchLink fieldCode="AU" term="%22Firth-Braun+J%22">Firth-Braun J</searchLink>; Kansas University Cancer Center, Kansas City, KS 66205, USA.<br /><searchLink fieldCode="AU" term="%22Godwin+AK%22">Godwin AK</searchLink>; Kansas University Cancer Center, Kansas City, KS 66205, USA; Department of Pathology and Laboratory Medicine, Kansas University Medical Center, Kansas City, KS 66160, USA.<br /><searchLink fieldCode="AU" term="%22Madan+R%22">Madan R</searchLink>; Department of Pathology and Laboratory Medicine, Kansas University Medical Center, Kansas City, KS 66160, USA.<br /><searchLink fieldCode="AU" term="%22Phadnis+M%22">Phadnis M</searchLink>; Department of Biostatistics, Kansas University Medical Center, Kansas City, KS 66160, USA.<br /><searchLink fieldCode="AU" term="%22Sun+W%22">Sun W</searchLink>; Department of Medicine, Division of Medical Oncology, Kansas University Medical Center, Kansas City, KS 66160, USA; Kansas University Cancer Center, Kansas City, KS 66205, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101766894%22">Cell reports. Medicine</searchLink> [Cell Rep Med] 2023 Feb 21; Vol. 4 (2), pp. 100916. <i>Date of Electronic Publication: </i>2023 Jan 25.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Cell+Press%22">Cell Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101766894 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2666-3791 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226663791%22">26663791 </searchLink><i>NLM ISO Abbreviation: </i>Cell Rep Med <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36702123
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.xcrm.2023.100916
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 100916
    Titles:
      – TitleFull: Cabozantinib plus durvalumab in advanced gastroesophageal cancer and other gastrointestinal malignancies: Phase Ib CAMILLA trial results.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Saeed A
      – PersonEntity:
          Name:
            NameFull: Park R
      – PersonEntity:
          Name:
            NameFull: Dai J
      – PersonEntity:
          Name:
            NameFull: Al-Rajabi R
      – PersonEntity:
          Name:
            NameFull: Kasi A
      – PersonEntity:
          Name:
            NameFull: Baranda J
      – PersonEntity:
          Name:
            NameFull: Williamson S
      – PersonEntity:
          Name:
            NameFull: Saeed A
      – PersonEntity:
          Name:
            NameFull: Ripp J
      – PersonEntity:
          Name:
            NameFull: Collins Z
      – PersonEntity:
          Name:
            NameFull: Mulvaney K
      – PersonEntity:
          Name:
            NameFull: Shugrue M
      – PersonEntity:
          Name:
            NameFull: Firth-Braun J
      – PersonEntity:
          Name:
            NameFull: Godwin AK
      – PersonEntity:
          Name:
            NameFull: Madan R
      – PersonEntity:
          Name:
            NameFull: Phadnis M
      – PersonEntity:
          Name:
            NameFull: Sun W
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 21
              M: 02
              Text: 2023 Feb 21
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2666-3791
          Numbering:
            – Type: volume
              Value: 4
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Cell reports. Medicine
              Type: main
ResultId 1